首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents
【24h】

Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents

机译:结构 - 活性关系研究3,5-二硝基苯基四唑作为抗细胞剂

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, we described the structure-activity relationships of substituted 3,5-dinitrophenyl tetrazoles as potent antitubercular agents. These simple and readily accessible compounds possessed high in vitro antimycobacterial activities against Mycobacterium tuberculosis, including clinically isolated multidrug (MDR) and extensively drug-resistant (XDR) strains, with submicromolar minimum inhibitory concentrations (MICs). The most promising compounds showed low in vitro cytotoxicity and negligible antibacterial and antifungal activities, highlighting their highly selective antimycobacterial effects. 2-Substituted 5-(3,5- dinitrophenyl)-2H-tetrazole regioisomers, which are the dominant products of 5(3,5- dinitrophenyl)-1H-tetrazole alkylation, showed better properties with respect to antimycobacterial activity and cytotoxicity than their 1-substituted counterparts. The 2-substituent of 5-(3,5dinitrophenyl)-2H-tetrazole can be easily modified and can thus be used for the structure optimization of these promising antitubercular agents. The introduction of a tetrazole-5-thioalkyl moiety at position 2 of the tetrazole further increased the antimycobacterial activity. These compounds showed outstanding in vitro activity against M. tuberculosis (MIC values as low as 0.03 mM) and high activity against non-tuberculous mycobacterial strains. (C) 2017 Elsevier Masson SAS. All rights reserved.
机译:在这项研究中,我们描述了取代的3,5-二硝基苯苯基四唑的结构 - 活性关系作为有效的抗细胞剂。这些简单易于无障碍的化合物具有对抗细胞分枝杆菌的体外抗细菌活性高,包括临床上分离的多药(MDR)和广泛的耐药性(XDR)菌株,具有亚微粒溶胶最小抑制浓度(MICS)。最有前途的化合物显示出低体外细胞毒性和可忽略的抗菌和抗真菌活动,突出了它们的高度选择性抗细管效应。 2-取代的5-(3,5-二硝基苯基)-2H-四唑的测定剂,其是5(3,5-二硝基苯基)-1H-四唑烷基化的优势产物,表现出与抗纤维杆菌活性和细胞毒性的更好的性能1取代的对应物。可以容易地修饰5-(3,5丁苯基)-2H-四唑的2-取代基,因此可以用于这些有前途的抗细胞剂的结构优化。在四唑2的位置引出四唑-5-硫代烷基部分进一步增加了抗致细胞活性。这些化合物显示出突显的体外活性对抗M.结核病(MIC值低至0.03mm),对非结核性分枝菌菌株的高活性。 (c)2017年Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号